Why Sarepta Therapeutics Tumbled Today
On the back of two pieces of news released after market hours on Tuesday, Sarepta Therapeutics (NASDAQ: SRPT) stock fell by over 12% today. Investors were displeased with a company update about its fundamentals, and a new share issue.
In separate press releases, Sarepta gave investors a glimpse of its upcoming third-quarter earnings release, and provided details of that share issue.
Source Fool.com